We are live on ! Find out more
SIC

Starr International Company Portfolio holdings

AUM $19.9M
1-Year Est. Return 39.69%
This Fund
S&P 500
This Quarter Est. Return
+0.04%
1 Year Est. Return
-39.69%
3 Year Est. Return
-26.08%
5 Year Est. Return
-43.79%
10 Year Est. Return
-39.24%
AUM
$22.4M
AUM Growth
+$9.24M
Cap. Flow
+$9.99M
Cap. Flow %
44.6%
Top 10 Hldgs %
100%
Holding
5
New
2
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$5.17M
2
MRNA icon
Moderna
MRNA
+$4.67M
3
BCSF icon
Bain Capital Specialty
BCSF
+$142K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 57.24%
2 Financials 42.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BCSF icon
1
Bain Capital Specialty
BCSF
$833M
$7.66M 34.19%
750,462
+13,589
+2% +$142K
AZN icon
2
AstraZeneca
AZN
$267B
$5.1M 22.76%
+46,500
New +$5.17M
MRNA icon
3
Moderna
MRNA
$22.1B
$4.74M 21.17%
+67,000
New +$4.67M
JNJ icon
4
Johnson & Johnson
JNJ
$643B
$2.98M 13.3%
20,000
– –
AIG icon
5
American International
AIG
$42.9B
$1.92M 8.57%
69,681
– –

Similar funds

DOS
David O. Sacks $19.8M AUM 4.02% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return
LUGPI
Lightspeed Ultimate General Partner IX Menlo Park, California $20.3M AUM 4.78% 1-Year Est. Return
CVSCT
C.V. Starr & Co Trust New York $19.4M AUM 28.57% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
CCFM
Cohen & Co Financial Management New York $18.3M AUM 73.48% 1-Year Est. Return
VNB
Virginia National Bank Charlottesville, Virginia $21.9M AUM 12.04% 1-Year Est. Return

Starr International Company's Q3 2020 Portfolio in Review

As of Q3 2020, Starr International Company held 5 positions worth $22.4M, up 70% from $13.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Starr International Company deployed $9.99M of net new capital in Q3 2020, opening 2 new positions and adding to 1 existing holding. Its largest new stake was AstraZeneca: 46,500 shares worth $5.1M.

By sector, the portfolio is most concentrated in Healthcare at 57% of assets, up from 21% a quarter earlier, followed by Financials.

  • Starr International Company's largest Q3 2020 buy was AstraZeneca: 46,500 shares worth $5.1M.
  • Starr International Company added most to Bain Capital Specialty in Q3 2020, an estimated $142K increase.
  • Starr International Company's ten largest holdings make up 100% of its $22.4M portfolio in Q3 2020.
  • Starr International Company opened 2 new positions and closed 0 in Q3 2020.
  • Starr International Company's portfolio value rose 70% quarter-over-quarter to $22.4M.

Based on Starr International Company's 13F filing for Q3 2020, filed 9 Oct 2020.